cryogel-based whole-cell cancer vaccine (Wyss Institute for Biologically Inspired Engineering/Dana-Farber Cancer Institute)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecryogel-based whole-cell cancer vaccine (Wyss Institute for Biologically Inspired Engineering/Dana-Farber Cancer Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyss Institute for Biologically Inspired Engineering
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteWyss Institute for Biologically Inspired Engineering
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A